W. Richter (Heidelberg, DE)

Orthopaedic University Hospital Heidelberg Research Centre for Experimental Orthopaedics
Prof. Dr. W. Richter is a Full Professor and Director of the Research Centre for Experimental Orthopaedics at Heidelberg University; Germany. She has been a leader in the field of cellular and molecular cartilage research pioneering the use of mesenchymal stroma cells for cartilage and intervertebral disk repair and the application of high throughput screening technologies for cartilage assessment. As a molecular biologist she received her Ph.D. at Ulm University; Germany and gained her post-doctoral experience at the University of California San Francisco and University of Ulm; where she completed her Habilitation in Experimental Medicine. She is a faculty member of Heidelberg University since 1998 and holds a chair for Experimental Orthopaedics since 2004. She has been President of the Basic Research Association of the German Society for Orthopaedic Surgery from 2005-2010; was a Board Member of EORS (2006-2011) and is member of ICRS since 2005. She is the scientific program director together with Kai Mithoefer at the ICRS 2013 conference. Wiltrud Richter's research has been focused on molecular and cellular aspects of stem cell and chondrocyte biology; mesenchymal stroma cell differentiation; tissue engineering; biomaterials and growth factor development and testing. She has been awarded several prices including the Wilhelm-Roux-Award of the German Orthopaedic Research Society; the Sandoz price for therapeutic research and the Mario Boni Award.

Presenter Of 1 Presentation

Podium Presentation Stem Cells

12.2.6 - Sulfation of Glycosaminoglycan Hydrogels Instructs Chondral Versus Endochondral Lineage Decision of Mesenchymal Stroma Cells In Vivo

Presentation Topic
Stem Cells
Date
13.04.2022
Lecture Time
17:06 - 17:15
Room
Potsdam 3
Session Type
Free Papers
Disclosure
No Significant Commercial Relationship

Abstract

Purpose

Exit from multipotency and lineage commitment of mesenchymal stroma cells (MSC) depends on microenvironmental cues from the stem-cell niche but steering cell-fate into the desired lineage in vivo remains a challenge. Increasing evidence suggests that glycosaminoglycans can be used to activate or sequester growth factors with the specific action depending on sulfation levels. We postulated that differentially sulfated biomaterials can aid developmental lineage instruction of MSC to guide tissue morphogenesis in vivo.

Methods and Materials

Injectable TGFβ-loaded-hydrogels designed at selected different sulfation status of the covalently coupled glycosaminoglycan, to grow true articular-cartilage-like tissue from MSC in vivo, were implanted into subcutaneous pouches of immunodeficient mice. The chondrogenic differentiation, hypertrophy and mineralization were investigated on day-28 and 56 explants by histology, ELISA, qPCR, WB and µCT analysis.

Results

By application of a new injectable TGFβ-loaded-hydrogel we here gained the ability to control skeletal stem-cell fate in vivo down the chondral versus the endochondral pathway depending on the sulfation status of the covalently coupled glycosaminoglycan. High sulfation allowed for long-term TGFβ-retention and silencing of Hedgehog-, BMP- and WNT-pathways and installed pro-chondrogenic and anti-hypertrophic cues in MSC. This permitted in vivo growth of permanent, collagen-type-II-rich neocartilage with long-term resistance to calcification and bone formation. Reduction of sulfation supported Hedgehog/BMP/WNT-signaling switching lineage commitment into endochondral differentiation with strong hypertrophic/osteogenic marker expression, tissue calcification and bone formation.icrs 2022 abstract_chasan-picture1.png

Conclusion

Our work identifies glycosaminoglycan sulfation as crucial niche instruction signal to determine the chondral stem-cell fate via silencing of prohypertrophic growth factor pathways providing the first proof-of-principle how glycosaminoglycan modification-patterns can determine cell lineage-choice during tissue morphogenesis in vivo.

Collapse

Moderator Of 1 Session

Bellevue Free Papers
Session Type
Free Papers
Date
14.04.2022
Time
11:15 - 12:45
Room
Bellevue
CME Evaluation (becomes available 5 minutes after the end of the session)